Micrometer-sized thread-like and/or spherical particles in the first fraction of cerebrospinal fluid in patients with bipolar disorder

Bipolar Disorders

Volumn 12, Issue 3, 2010, Pages 298-305

  Båve, Ullvi ^a   Nybom, Rolf ^b   Landén, Mikael ^a,c   Wetterberg, Lennart ^a  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bipolar disorder; Blood brain barrier; Cerebrospinal fluid gradient; CSF serum albumin ratio; Depression; Mania; Morphological structure; Scanning electron microscopy

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PROPIOMAZINE; QUETIAPINE; SERUM ALBUMIN; VALPROIC ACID; ALBUMINOID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SPHERICAL PARTICLE; BIPOLAR DISORDER; CEREBROSPINAL FLUID; CHEMISTRY; CLASSIFICATION; MIDDLE AGED; NONPARAMETRIC TEST; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; BIPOLAR DISORDER; CEREBROSPINAL FLUID; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 77953927409     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00805.x     Document Type: Article

References (26)

1. Sönnerborg A, Nybom R, Britton S. Detection of cell-free human immunodeficiency virus in cerebrospinal fluid by using immune scanning electron microscopy. J Infect Dis 1989, 159:1037-1041.
2. Andersson J, Nybom R, Larsson P, Andersson U, Britton S, Ehrnst A. Rapid detection of cytomegalovirus using immune scanning electron microscopy. J Virol Methods 1987, 16:253-262.
3. Wetterberg L, Nybom R, Bratlid T, Fladby T, Olsson B, Wigzell H. Micrometer-sized particles in cerebrospinal fluid (CSF) in patients with schizophrenia. Neurosci Lett 2002, 329:91-95.
4. Post RM, Speer AM, Hough CJ, Xing G. Neurobiology of bipolar illness: implications for future study and therapeutics. Ann Clin Psychiatry 2003, 15:85-94.
5. Shao L, Vawter MP. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 2008, 64:89-97.
6. Lichtenstein P, Yip BH, Björk C. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
7. Yang S, Wang K, Gregory B. Genomic landscape of a three-generation pedigree segregating affective disorder. PLoS ONE 2009, 4:e4474.
8. Blennow K, Fredman P, Wallin A, Gottfries CG, Långström G, Svennerholm L. Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. Euro Neurol 1993, 33:126-128.
9. Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) 1994, Washington D.C., American Psychiatric Association
10. Sachs GS, Thase ME, Otto MW. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003, 53:1028-1042.
11. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992, 49:624-629.
12. Sheehan DV, Lecrubier Y, Sheehan KH. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59:22-33.
13. International Statistical Classification of Diseases and Related Health Problems 10th Revision ICD-10 1994, Geneva, WHO
14. Blennow K, Fredman P, Wallin A. Protein analyses in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Euro Neurol 1993, 33:129-133.
15. Elfont RM, Griffin DE, Goldstein GW. Enhanced endothelial cell adhesion of human cerebrospinal fluid lymphocytes. Ann Neurol 1995, 38:405-413.
16. Harris LW, Wayland M, Lan M. The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS ONE 2008, 3:e3964.
17. Ekelund J, Wahlbeck K, Back N. No association between micrometer-sized particles in human cerebrospinal fluid and schizophrenia. Neurosci Lett 2003, 349:68-70.
18. Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res 2008, 5:10.
19. Pitts AF, Carroll BT, Gehris TL, Kathol RG, Samuelson SD. Elevated CSF protein in male patients with depression. Biol Psychiatry 1990, 28:629-637.
20. Hooper C, Pinteaux-Jones F, Fry VA. Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damage. J Neurochem 2009, 109:694-705.
21. Knijff EM, Breunis MN, Kupka RW. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord 2007, 9:743-753.
22. Rapaport MH, Manji HK. The effects of lithium on ex vivo cytokine production. Biol Psychiatry 2001, 50:217-224.
23. Boufidou F, Nikolaou C, Alevizos B, Liappas IA, Christodoulou GN. Cytokine production in bipolar affective disorder patients under lithium treatment. J Affect Disord 2004, 82:309-313.
24. Silva R, Martins L, Longatto-Filho A, Almeida O, Sousa N. Lithium prevents stress-induced reduction of vascular endothelium growth factor levels. Neurosci Lett 2007, 429:33-38.
25. Nilsson A, Axelsson R. Factors associated with discontinuation of long-term lithium treatment. Acta Psych Scand 1989, 80:221-230.
26. Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 2008, 13:470-479.